Conference call and web cast scheduled for 9:00 a.m. eastern time
ArQule, Inc. (NASDAQ: ARQL) today announced that it will report its
financial results for the second quarter of 2008 in a press release to
be issued on Monday, August 11, 2008 at 7:00 a.m. eastern time. The
Company will host a conference call and web cast to discuss these
results at 9:00 a.m. eastern time on that day.
|
Conference call details
|
|
|
|
|
|
|
|
Date:
|
|
Monday, August 11, 2008
|
|
Time:
|
|
9:00 a.m. ET
|
|
Conference Call Numbers
|
|
|
|
Domestic:
|
|
866-362-4820
|
|
International:
|
|
617-597-5345
|
|
Participant Passcode:
|
|
55588807
|
|
Web cast:
|
|
http://www.arqule.com
|
A replay of the conference call will be available for seven days
following the call and can be accessed by dialing toll-free 888-286-8010
and outside the U.S. 617-801-6888. The access code is 60157973.
About ArQule
ArQule is a biotechnology company engaged in the research and
development of next-generation, small-molecule cancer therapeutics. The
Company’s targeted, broad-spectrum products
and research programs are focused on key biological processes that are
central to cancer. ArQule’s clinical-stage
products consist of ARQ 197, an inhibitor of the c-Met receptor tyrosine
kinase, and ARQ 501, an activator of the cell’s
DNA damage response mechanism mediated by the E2F-1 transcription
factor. The Company’s most advanced
pre-clinical development programs are focused on ARQ 761, a
second-generation E2F-1 activator, as well as compounds that inhibit the
Eg5 kinesin spindle protein and the B-RAF kinase. ArQule’s
discovery efforts are focused on the identification of novel kinase
inhibitors that are potent, selective and do not compete with ATP
(adenosine triphosphate), an energy source for cells. For more
information, please visit www.arqule.com.
ArQule, Inc.
William B. Boni, 781-994-0300
VP, Investor
Relations/
Corp. Communications
www.ArQule.com
